Results 151 to 160 of about 28,350 (246)

Molecular Mechanisms and Therapeutic Strategies in Heart Failure Due to Dystrophin Deficiency: A Comprehensive Review. [PDF]

Rev Cardiovasc Med
Yu W, Wang W, Luo F, Zhao Y, Wu Q, Li P.
europepmc   +1 more source

YAP Acts as a Negative Regulator of Mini Utrophin-Based Gene Therapy for Duchenne Muscular Dystrophy in Mdx Mice. [PDF]

Int J Mol Sci
Li Z, Song Y.
europepmc   +1 more source

Emerging roles of microRNAs and other non-coding transcriptome in muscular dystrophies. [PDF]

Inflamm Regen
Abdelrehim FG, Sadek Z, Fahim SA, El-Ekiaby N, Abdelaziz AI, Fawzy IO.   +5 more
europepmc   +1 more source

Duchenne Muscular Dystrophy: Contemporary Therapeutic Options and Real-World Challenges in Treatment Selection. [PDF]

Muscles
Pesco MT, Öztürk GZ, Bhadola SC, Chrzanowski SM, Gushchina LV, D'Ambrosio ES.   +5 more
europepmc   +1 more source

Viscoelastic properties of dystrophin-deficient mouse skeletal muscles are resilient to isometric fatiguing exercise. [PDF]

Physiol Rep
Merry DL, Devananthan P, Kabaliuk N, Lindsay A.   +3 more
europepmc   +1 more source

Nicotinamide and Pyridoxine Supplementation Enhances Muscle Stem Cell Activity and Muscle Regeneration in Humans: A Randomized Placebo-Controlled Clinical Trial of High Force Eccentric Contraction Recovery in Healthy Young Men. [PDF]

Adv Sci (Weinh)
Højfeldt G, Michaud J, Damgaard A, Karlog K, Migliavacca E, Karaz S, Pazirandeh-Micol E, Johansen OE, Karagounis LG, Helge BW, Hagemann W, Kjaer M, Feige JN, Stuelsatz P, Mackey AL.   +14 more
europepmc   +1 more source

RNA Therapeutics for Duchenne Muscular Dystrophy: Exon Skipping, RNA Editing, and Translational Insights from Genome-Edited Microminipig Models. [PDF]

Int J Mol Sci
Chassin A, Ono H, Ashida Y, Imamura M, Aoki Y.   +4 more
europepmc   +1 more source

Dystrophin-Deficient Cardiomyopathy Due to a Novel Hemizygous DMD Indel Variant. [PDF]

JACC Case Rep
Albrecht K, Averbuch T, Huculak C, Marcadier J, Oudit G, van Landeghem FKH, Adam B, Lyons KJ, Kiamanesh O.   +8 more
europepmc   +1 more source

Bioengineered AAV9 and Optimised Microdystrophin Vectors Augment Phenotypic Rescue in a Murine Model of Duchenne Muscular Dystrophy. [PDF]

J Cell Mol Med
Senthilkumar MB, Sharma S, Srinivasan N, Varghese A, Sarangi P, Singh V, Kumar N, Yenurkar D, Mukherjee S, Amit S, Bhatia S, Misra SK, Puri RD, Chamberlain J, Jayandharan GR.   +14 more
europepmc   +1 more source

Preclinical evaluation of INS1201 AAV9-micro-dystrophin via CSF administration as a potential therapy for Duchenne muscular dystrophy. [PDF]

Mol Ther Adv
Thomsen G, Kaspar A, Ferraiuolo L, Chu B, Garcia VJ, Weiss R, Slaiwa T, Casanova-Vallve N, Cano R, Hurley E, Julazadeh H, Bautista H, Renteria A, Lee M, Rollins J, McAlonis-Downes M, Arnold WD, TreDenick T, Hsu R, Bayless LE, Kozial C, Forespring C, Molony M, Fraser M, Zhou J, Yao J, Bremner SN, Ward SR, Schenk S, Yoshikawa T, Moriyama A, Tsusaki H, Varma S, Kruger M, Stahl M, Kaspar B.   +35 more
europepmc   +1 more source